Brookline Capital Acquisition Corp.
Status: Closed Deal
U=S+W/2
W=S@11.5
| IPO Proceeds, $M | $57.50M |
|---|---|
| IPO Date | Jan 29, 2021 |
| CEO | Dr. Samuel P. Wertheimer |
| Left Lead | Ladenburg Thalmann |
| IPO Cash in Trust | 101.0% |
| SPAC Tenor | 15 + 6 |
| IPO Sector | Healthcare ▶ |
| IPO Geography | US/Canada |
| Target Company | Apexigen, Inc. |
| Deal Announced | Mar 18, 2022 |
| Deal Size, $M | $287.00M |
| Deal Sector | Healthcare |
| Deal Geography | US/Canada |
| SEC Filings |
www.sec.gov 
|
| Approval Vote | Jul 27, 2022 |
| Amendment Vote | Apr 26, 2022 |
| Closing Date | Jul 29, 2022 |
Formerly BCAC
APGN
APGNW
| Price | 2.52 |
|---|---|
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in to view structure, cap table, and calendar of events.